These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3118057)

  • 21. Topical mitomycin C therapy for carcinoma in situ of the bladder: a followup.
    Stricker PD; Grant AB; Hosken BM; Taylor JS
    J Urol; 1990 Jan; 143(1):34-5; discussion 35-6. PubMed ID: 2104637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Blood and tissue levels of mitomycin C after intravesical instillation].
    Flüchter SH; Hlobil H; Harzmann R; Rothe KF; Bichler KH
    Urol Int; 1983; 38(6):321-8. PubMed ID: 6419427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of mitomycin C perfusion after bladder tumor surgery].
    Zhou CL
    Zhonghua Wai Ke Za Zhi; 1989 Nov; 27(11):654-5, 700. PubMed ID: 2517250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prophylaxis of recurrence of superficial bladder tumor by diluted postoperative continuous intravesical instillation of anti-tumor solutions].
    Uchida T; Kobayashi K; Honda N; Arakawa T; Omata T; Endo T; Ishibashi A; Koshiba K
    Nihon Hinyokika Gakkai Zasshi; 1985 Mar; 76(3):354-9. PubMed ID: 2411987
    [No Abstract]   [Full Text] [Related]  

  • 25. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
    Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
    Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intensive intravesical chemotherapy in the treatment of flat carcinoma in situ: is it safe?
    Droller MJ; Walsh PC
    J Urol; 1985 Dec; 134(6):1115-7. PubMed ID: 3932686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bladder wall calcification after intravesical mitomycin C treatment of superficial bladder cancer.
    Drago PC; Badalament RA; Lucas J; Drago JR
    J Urol; 1989 Oct; 142(4):1071-2. PubMed ID: 2507794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incrusted cystitis after intravesical mitomycin C treatment.
    Llopis M; Moreno J; Botella R; Algado M
    Acta Urol Belg; 1993 Sep; 61(3):21-3. PubMed ID: 8256682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Papillary-like bladder calcifications following intravescical mitomycin C. A case report.
    Fiore AA; Iorio B; Vennarecci G; Venditti D; Cervelli V; Giudiceandrea F; Casciani CU
    Minerva Urol Nefrol; 1993 Dec; 45(4):171-3. PubMed ID: 8023227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravesical mitomycin C for superficial transitional cell carcinoma.
    Bolenz C; Cao Y; Arancibia MF; Trojan L; Alken P; Michel MS
    Expert Rev Anticancer Ther; 2006 Aug; 6(8):1273-82. PubMed ID: 16925493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vesicoureteral reflux in recurrent carcinoma of the bladder--implications for treatment and prognosis.
    Schmidt JD; Jacobo EC; Weinstein SH
    J Urol; 1976 Dec; 116(6):734-6. PubMed ID: 826656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severely contracted bladder following intravesical mitomycin C therapy.
    Wajsman Z; McGill W; Englander L; Huben RP; Pontes JE
    J Urol; 1983 Aug; 130(2):340-1. PubMed ID: 6410085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal failure after intravesical mitomycin C.
    Farha AJ; Krauss DJ
    Urology; 1989 Oct; 34(4):216-7. PubMed ID: 2508290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transitional cell carcinoma of the prostate following intravesical therapy for transitional cell carcinoma of the bladder.
    Hardeman SW; Perry A; Soloway MS
    J Urol; 1988 Aug; 140(2):289-92. PubMed ID: 3135420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Complications of intravesical mitomycin chemotherapy, apropos of 2 clinical case reports].
    Pouya M; Opsomer RJ; Wese FX; Saleh M; Donnay M; Van Cangh PJ
    Acta Urol Belg; 1996 Mar; 64(1):47-53. PubMed ID: 8659335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upper urinary tract transitional cell carcinoma in patients with bladder carcinoma and associated vesicoureteral reflux.
    Amar AD; Das S
    J Urol; 1985 Mar; 133(3):468-71. PubMed ID: 3973999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upper tract tumours in patients with vesico-ureteral reflux and recurrent bladder tumours.
    Mukamel E; Nissenkorn I; Glanz I; Vilcovsky E; Servadio C
    Eur Urol; 1985; 11(1):6-8. PubMed ID: 3987750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resection of the Intramural Portion of the Distal Ureter during Transurethral Resection of Bladder Tumors: Predictive Factors for Secondary Stenosis and Development of Upper Urinary Tract Recurrence.
    Rodriguez Faba O; Gaya JM; Breda A; Juarez Del Dago P; Pisano F; Salas D; Palou J
    J Urol; 2016 Jul; 196(1):52-6. PubMed ID: 26802584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Primary carcinoma in situ of the ureter: a case report].
    Kawakami S; Yamada T; Watanabe T; Masuda H; Nagahama K; Nagamatsu H; Negishi T
    Hinyokika Kiyo; 1992 Dec; 38(12):1391-3. PubMed ID: 1288229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravesical mitomycin C for the treatment of recurrent superficial bladder tumours.
    Hetherington JW; Newling DW; Robinson MR; Smith PH; Adib RS; Whelan P
    Br J Urol; 1987 Mar; 59(3):239-41. PubMed ID: 3105631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.